Association of BDNF Val66Met Polymorphism and Brain BDNF Levels with Major Depression and Suicide
Author(s) -
Mariam M. Youssef,
Mark D. Underwood,
Yungyu Huang,
Shuchi Hsiung,
Yan Liu,
Norman R. Simpson,
Mihran J. Bakalian,
Gorazd Rosoklija,
Andrew J. Dwork,
Victoria Arango,
J. John Mann
Publication year - 2018
Publication title -
the international journal of neuropsychopharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.897
H-Index - 107
eISSN - 1469-5111
pISSN - 1461-1457
DOI - 10.1093/ijnp/pyy008
Subject(s) - neurotrophic factors , psychology , brain derived neurotrophic factor , major depressive disorder , anterior cingulate cortex , medicine , neuroscience , dorsolateral prefrontal cortex , neurotrophin , psychiatry , prefrontal cortex , endocrinology , amygdala , cognition , receptor
Brain-derived neurotrophic factor is implicated in the pathophysiology of major depressive disorder and suicide. Both are partly caused by early life adversity, which reduces brain-derived neurotrophic factor protein levels. This study examines the association of brain-derived neurotrophic factor Val66Met polymorphism and brain brain-derived neurotrophic factor levels with depression and suicide. We hypothesized that both major depressive disorder and early life adversity would be associated with the Met allele and lower brain brain-derived neurotrophic factor levels. Such an association would be consistent with low brain-derived neurotrophic factor mediating the effect of early life adversity on adulthood suicide and major depressive disorder.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom